Amneal Pharmaceuticals, Inc.AMRXNASDAQ
Loading
Interest Expense Over TimeStrong
Percentile Rank91
3Y CAGR+15.0%
5Y CAGR+10.6%
Year-over-Year Change
Interest expense on outstanding debt
3Y CAGR
+15.0%/yr
vs +2.5%/yr prior
5Y CAGR
+10.6%/yr
Recent acceleration
Acceleration
+12.6pp
Accelerating
Percentile
P91
Near historical high
vs 5Y Ago
1.7x
Solid growth
Streak
1 yr
Consecutive declineStrong
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $241.09M | -6.8% |
| 2024 | $258.60M | +22.8% |
| 2023 | $210.63M | +33.0% |
| 2022 | $158.38M | +16.2% |
| 2021 | $136.32M | -6.6% |
| 2020 | $146.00M | -13.2% |
| 2019 | $168.21M | +17.2% |
| 2018 | $143.57M | +102.0% |
| 2017 | $71.06M | +28.5% |
| 2016 | $55.28M | - |